Products Markets Manufacturing Services Blog Who We Are Investor Relations English Home » Investor Relations » Corporate Governance » Board of Directors Board of Directors Your trusted and focused solution partner since 1923 Share Ticker Elos Medtech B (ELOS B) Latest +/- % Ask Bid 304 -16 -5.00 304 301 Last update: 4 December 2021, 9:22 This post is also available in: Svenska Within the Board, there is an Audit Committee. The Audit Committee comprises Jon Risfelt and Lovisa Lander. Yvonne Mårtensson Chairman of the Board Born: 1953 Master of Engineering of Industrial Economics at Linköping University of Technology. Director since 2015. Chairman of the Board since 2017. Other assignments: Director of the Board of Xvivo Perfusion AB, Boule Diagnostics AB and Lyfstone A/S. Shareholding: - Dependence: Independent of the company and major shareholders. Jon Risfelt Board director Born: 1961 Master of Science in Chemical Engineering at the Royal Institute of Technology. Director since 2017. Other assignments: Chairman of the Board Knowit AB, CAB Group AB and Axentia Group Holding AB. Board member of Bilia AB, Boule Diagnostics AB and Projektengagemang AB. Shareholding: - Dependence: Independent of the company and major shareholders. Birker B. Bahnsen Board director Born: 1977 Holds a master’s degree in Engineering from Cambridge University and an MSc in Cognitive Psychology from Oxford University. Director since 2021. Other assignments: Is working at TA Associates since 2009, where his current position is Managing Director and Head of European Healthcare. He has previous experience from the investment bank Goldman Sachs. Shareholding: - Dependence: Independent of the company. Not independent in relation to Elos Medtech AB's major shareholders. Lovisa Lander Board director Born: 1985 Holds a master’s degree in Engineering from Chalmers University of Technology. Director since 2021. Other assignments: Is working at TA Associates since 2010, where her current position is Principal focused on TA Associates’ European Healthcare investments. She has previous experience from Rothchild. Shareholding: - Dependence: Independent of the company. Not independent in relation to Elos Medtech AB's major shareholders. Alexander Cicetti Board director Born: 1991 Holds a Masters’ degree in Management from the University of Mannheim. Director since 2021. Other assignments: Is working at TA Associates since 2020 in TA Associates’ European Healthcare team. He has previous experience from the investment bank J.P. Morgan. Shareholding: - Dependence: Independent of the company. Not independent in relation to Elos Medtech AB's major shareholders. CALENDAR Feb 24, 2022 Year-end Report 2021 April, 2022 Annual Report 2021 April 26, 2022 Interim Report Q1, 2022 May 3, 2022 Annual General Meeting 2022 Aug 18, 2022 Interim Report Q2, 2022 Oct 21, 2022 Interim Report Q3, 2022 Feb 23, 2023 Year-end Report 2022 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Elos Medtech Interim Report January 1 - September 30, 2021 20 Oct 2021, 08:00 Elos Medtech Nomination Committee appointed for the 2022 Annual General Meeting 27 Sep 2021, 11:30 PRESS RELEASES & REGULATORY INFORMATION Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ) 29 Nov 2021, 16:30 Financial / IR information STAY UPDATED! Subscribe to our newsletter SUBSCRIBE Copyright © 2021 by Elos Medtech AB. All rights reserved. Cookies & Privacy Policy Follow us: This website uses cookies to provide you with the best browsing experience. Find out more or adjust your settings. Accept